High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease

QR Code

High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease

Objectives: Patients with chronic kidney disease (CKD) often present with reduced plasma HDL cholesterol (HDL-C) levels. Whether this reduction in an epiphenomenon or is involved in disease progression is unclear. The aim of this study was to investigate the relation between HDL-C levels/function an...

Full description

Bibliographic Details
Main Authors:	Baragetti, A., Norata, Giuseppe, Sarcina, C., Rastelli, F., Grigore, L., Garlaschelli, K., Uboldi, P., Baragetti, I., Pozzi, C., Catapano, A.
Format:	Journal Article
Published:	2013
Online Access:	http://hdl.handle.net/20.500.11937/55123

Similar Items

-374 T/A RAGE Polymorphism Is Associated with Chronic Kidney Disease Progression in Subjects Affected by Nephrocardiovascular Disease
by: Baragetti, I., et al.
Published: (2013)

Long pentraxin PTX3 as a prognostic marker of cardiovascular mortality in patients with chronic kidney disease
by: Baragetti, A., et al.
Published: (2017)

Treating high density lipoprotein cholesterol (HDL-C): Quantity versus quality
by: Pirillo, A., et al.
Published: (2013)

Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials
by: Catapano, A., et al.
Published: (2017)

Genetically determined telomeres shortening is associated with carotid atherosclerosis progression and increased incidence of cardiovascular events
by: Baragetti, A., et al.
Published: (2016)

IDOL N342S variant, atherosclerosis progression and cardiovascular disorders in the italian general population
by: Dhyani, A., et al.
Published: (2015)

Biology of proprotein convertase subtilisin kexin 9: Beyond low-density lipoprotein cholesterol lowering
by: Norata, Giuseppe, et al.
Published: (2016)

Proprotein Convertase Subtilisin-Kexin type-9 (PCSK9) and triglyceride-rich lipoprotein metabolism: Facts and gaps
by: Baragetti, A., et al.
Published: (2018)

The missing link between high-density lipoprotein cholesterol and inflammatory response in cardiovascular disease
by: Ammirati, E., et al.
Published: (2014)

High density lipoproteins and atherosclerosis: Emerging aspects
by: Sala, F., et al.
Published: (2012)

The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
by: Pirillo, A., et al.
Published: (2018)

High-density lipoprotein subfractions - What the clinicians need to know
by: Pirillo, A., et al.
Published: (2013)

Subclinical atherosclerosis is associated with Epicardial Fat Thickness and hepatic steatosis in the general population
by: Baragetti, A., et al.
Published: (2016)

MicroRNAs and lipoproteins: A connection beyond atherosclerosis?
by: Norata, Giuseppe, et al.
Published: (2013)

Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population
by: Baragetti, A., et al.
Published: (2014)

Translating the biology of adipokines in atherosclerosis and cardiovascular diseases: Gaps and open questions
by: Ruscica, M., et al.
Published: (2017)

Long pentraxin 3: Experimental and clinical relevance in cardiovascular diseases
by: Bonacina, F., et al.
Published: (2013)

Statins and periodontal inflammation: A pleiotropic effect of statins or a pleiotropic effect of LDL-cholesterol lowering?
by: Norata, Giuseppe, et al.
Published: (2014)

Emerging role of high density lipoproteins as a player in the immune system
by: Norata, Giuseppe, et al.
Published: (2012)

Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?
by: Catapano, A., et al.
Published: (2017)

Telomere shortening over 6 years is associated with increased subclinical carotid vascular damage and worse cardiovascular prognosis in the general population
by: Baragetti, A., et al.
Published: (2015)

Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up
by: Fracanzani, A., et al.
Published: (2016)

Predictor of early diagnosis, diagnosis, or progression of acute kidney injury
by: Md Ralib, Azrina, et al.
Published: (2011)

Homozygous familial hypobetalipoproteinemia: Two novel mutations in the splicing sites of apolipoprotein B gene and review of the literature
by: Cefalù, A., et al.
Published: (2015)

Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases?
by: Nakamura, K., et al.
Published: (2009)

Effect of treatment with pravastatin or ezetimibe on endothelial function in patients with moderate hypercholesterolemia
by: Grigore, L., et al.
Published: (2013)

PCSK9 deficiency results in increased ectopic fat accumulation in experimental models and in humans
by: Baragetti, A., et al.
Published: (2017)

Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus
by: Ammirati, E., et al.
Published: (2014)

Efficacy of Ganoderma lucidum on plasma lipids and lipoproteins in rats fed with high cholesterol diet
by: Tong, Chow Chin, et al.
Published: (2008)

Epicardial Adipose Tissue (EAT) thickness is associated with cardiovascular and liver damage in nonalcoholic fatty liver disease
by: Fracanzani, A., et al.
Published: (2016)

Disease trends over time and CD4+CCR5+ T-cells expansion predict carotid atherosclerosis development in patients with systemic lupus erythematosus
by: Baragetti, A., et al.
Published: (2017)

The thyroid receptor modulator KB3495 reduces atherosclerosis independently of total cholesterol in the circulation in ApoE deficient mice
by: Mörk, L., et al.
Published: (2013)

Early effects of high cholesterol diet on the kidney of an animal model
by: Hamad Mohamed, Zenab, et al.
Published: (2017)

Early effects of high cholesterol diet on the kidney of an animal model
by: Hamad Mohamed, Zenab B., et al.
Published: (2018)

Heterozygous mthfr c677t polymorphism (rs1801133) is associated with higher total cholesterol/ high density lipoprotein cholesterol ratio in habitual coffee drinkers
by: Ong, Xuan
Published: (2023)

Factors associated with nonachievement of low density lipoprotein cholesterol target among patients with type 2 diabetes mellitus
by: Mat Yudin, Zainab
Published: (2015)

Leonurine: A new comer in the natural compounds affecting atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2012)

HDL and adaptive immunity: A tale of lipid rafts
by: Norata, Giuseppe, et al.
Published: (2012)

New therapeutic principles in dyslipidaemia: Focus on LDL and Lp(a) lowering drugs
by: Norata, Giuseppe, et al.
Published: (2013)

Developing The Prognostic Model Of Chronic Kidney Disease Progression And Elucidating The Global Prevalence Of Chronic Kidney Disease Depression Among Elderly
by: Khan, Irfanullah
Published: (2023)

Cannot write session to /tmp/vufind_sessions/sess_todou9n26ai9poffra5mrfk21b